Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-12-31

FDA Approved: NITROGLYCERIN IN DEXTROSE — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

FDA approved Baxter Healthcare Company's supplemental NDA for Nitroglycerin in Dextrose, authorizing the nitroglycerin-in-dextrose formulation under NDA 019970.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NITROGLYCERIN IN DEXTROSE (Nitroglycerin)

Snippet

SUPPL AP for NITROGLYCERIN IN DEXTROSE (NITROGLYCERIN)